Related references
Note: Only part of the references are listed.A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction
F. Klevebro et al.
ANNALS OF ONCOLOGY (2016)
New S3 guideline for esophageal cancer. Important surgical aspects
A. H. Hoelscher et al.
CHIRURG (2016)
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial
Salah-Eddin Al-Batran et al.
LANCET ONCOLOGY (2016)
Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT
Stefan Muench et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2016)
Neoadjuvant vs. adjuvant treatment of Siewert type II gastroesophageal junction cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry
Joseph A. Miccio et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2016)
Impact of Total Lymph Node Count on Staging and Survival After Neoadjuvant Chemoradiation Therapy for Rectal Cancer
Matthew D. Hall et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Esophageal and Esophagogastric Junction Cancers, Version 1.2015
Jaffer A. Ajani et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2015)
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Joel Shapiro et al.
LANCET ONCOLOGY (2015)
S3-Guidelines Diagnosis and Treatment of Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus (Long Version 1.0-September 2015, AWMF-Register Number: 021/023OL)
R. Porschen et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2015)
Low Lymph Node Retrieval After Preoperative Chemoradiation for Rectal Cancer is Associated with Improved Prognosis in Patients with a Good Tumor Response
Hun Jin Kim et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Optimal Management of Esophageal Adenocarcinoma: Should We Be CROSS?
Elizabeth C. Smyth et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Reply to EC Smyth et al
Maarten C. C. M. Hulshof et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: Systematic review with meta-analysis combining individual patient and aggregate data
Ulrich Ronellenfitsch et al.
EUROPEAN JOURNAL OF CANCER (2013)
Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus
Ulrich Ronellenfitsch et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
Marc Ychou et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
Katrin M. Sjoquist et al.
LANCET ONCOLOGY (2011)
Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954
Christoph Schuhmacher et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer
William H. Allum et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction
Michael Stahl et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781
Joel Tepper et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus - Five-year survival of a randomized clinical trial
Jikke M. T. Omloo et al.
ANNALS OF SURGERY (2007)
Long-term results of RTOG trial 8911 (USA intergroup 113): A random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer
David P. Kelsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial
Mitsuru Sasako et al.
LANCET ONCOLOGY (2006)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial
BH Burmeister et al.
LANCET ONCOLOGY (2005)
Share Paper
